STRS Ohio’s Aprea Therapeutics APRE Stock Holding History

STRS Ohio’s Portfolio APRE Stock Details APRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-85	Closed	-$8K	–	2233
2021 Q1	$8K	Hold	85	–	–	﹤0.01%	2135
2020 Q4	$8K	Hold	85	–	–	﹤0.01%	2113
2020 Q3	$40K	Hold	85	–	–	﹤0.01%	2004
2020 Q2	$65K	Hold	85	–	–	﹤0.01%	1867
2020 Q1	$59K	Hold	85	–	–	﹤0.01%	1761
2019 Q4	$78K	Buy	+85	New	+$46.8K	﹤0.01%	1822

Other funds holding APRE

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

PDT Partners New York $1.69B AUM 74.01% 1-Year Est. Return

STRS Ohio's APRE Position: Q2 2021 in Review

STRS Ohio sold out of Aprea Therapeutics (APRE) in Q2 2021, closing a stake of 85 shares — an estimated $8K sold.

STRS Ohio first reported a position in APRE in Q4 2019 and held it in 6 quarters. The position peaked at $78K in Q4 2019. 50 funds tracked by Wall St. Rank hold APRE as of Q2 2021.

STRS Ohio reported no remaining Aprea Therapeutics position as of Q2 2021 after selling out during the quarter.
STRS Ohio sold 85 Aprea Therapeutics shares in Q2 2021, an estimated $8K.
STRS Ohio first reported a position in Aprea Therapeutics in Q4 2019 and held it in 6 quarters.
STRS Ohio's Aprea Therapeutics position peaked at $78K in Q4 2019.
50 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q2 2021.

Based on STRS Ohio's 13F filing for Q2 2021, filed 26 Jul 2021.